Trial intelligence / Profile preview

Synvisc for Cartilage Preservation in Knee Osteoarthritis

NCT00393393Phase 4Unknown

Sponsor
Cabrini Health
Start
Jan 2006
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of sodium hyaluronate in osteoarthritis (OA), sponsored by Cabrini Health. Status: unknown.

02

Drugs

sodium hyaluronate
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00393393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00393393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call